Bayer Aktiengesellschaft (BAYN.DE)

55,94 -0,69 (-1,22%) Alla chiusura: 05:35PM CET

Bayer Aktiengesellschaft

Kaiser-Wilhelm-Allee 1
Leverkusen 51368
Germany
49 214 30 1
https://www.bayer.com

Settore/i: Healthcare
Settore: Drug Manufacturers—General
Impiegati a tempo pieno: 97.922

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Werner Baumann	Chairman of Management Board, CEO & Chief Sustainability Officer	4,99M	N/D	1962
Mr. Wolfgang U. Nickl	CFO & Member of Management Board	2,12M	N/D	1969
Mr. Heiko W. J. Schipper	Member of Management Board & Pres of the Consumer Health Division	1,92M	N/D	1969
Mr. Stefan Oelrich	Head of the Pharmaceuticals Division & Member of the Board of Management	2,08M	N/D	1968
Ms. Sarena S. Lin	Chief Transformation & Talent Officer, Labor Director and Member of Management Board	3,08M	N/D	1971
Mr. Rodrigo Santos	Member of Management Board & Pres of the Crop Science Division	2,17M	N/D	1973
Mr. Bernd-Peter Bier	Head of Accounting and Head of Taxes	N/D	N/D	1967
Mr. Oliver Maier	Head of Investor Relations	N/D	N/D	N/D
Dr. Gabriel Harnier	Head of Law, Patents & Compliance	N/D	N/D	1971
Mr. Michael Preuss	Head of Communications, Gov. Relations and Corp. Brand	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2022 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Governance aziendale

L'ISS Governance QualityScore di Bayer Aktiengesellschaft al 1 marzo 2023 è 5. I criteri di valutazione fondamentali sono revisione: 4; Consiglio di Amministrazione: 2; diritti degli azionisti: 1; retribuzione: 8.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.